Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Fimasartan/Amlodipine and Rosuvastatin
NCT02397538Phase 1Completed
- Sponsor
- Boryung
- Start
- Feb 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fimasartan in hypertension (HTN) and hypercholesterolemia (2 cohorts), sponsored by Boryung. Primary endpoints: Maximum Plasma Concentration at Steady State and Area Under the Curve over the Dosing Interval at Steady State. Started Feb 2015; status: completed.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02397538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397538.